NMN and NAD+: The Longevity Science Behind the Most Talked-About Supplement of 2026
- Juvenology Clinic
- 5 days ago
- 8 min read
There are three letters that keep appearing in longevity science conversations, in research journals, in clinic consultations, and increasingly in the questions patients bring to me at Juvenology.
NAD+.
It stands for nicotinamide adenine dinucleotide. It is one of the most important molecules in your body. And by your 40s, your levels of it have roughly halved compared to your 20s. By 60, they have declined further still. That decline is directly connected to how your cells age, repair themselves, and produce energy.
NMN, nicotinamide mononucleotide, is the precursor your body uses to make NAD+. It is the building block. And it is one of the most researched longevity compounds of the last decade, with scientists including David Sinclair at Harvard describing it as a genuine breakthrough in our understanding of cellular ageing.
At Juvenology, we stock HINNAO NMN for a specific reason: bioavailability. The science behind any supplement matters enormously, but only if what you are taking actually reaches your cells. Most NMN capsules do not. Here is why that distinction is critical, and what the research actually tells us about this remarkable molecule.
What NAD+ actually does in your body
NAD+ is not simply an energy molecule. It governs DNA repair, cellular senescence, mitochondrial function, and the sirtuins, a family of proteins that act as the body's longevity regulators.
Let me explain each of these in turn.
At the most fundamental level, NAD+ sits at the centre of cellular energy metabolism. Every time your mitochondria convert nutrients into ATP, the currency your cells use for every function, NAD+ is involved as a co-factor. It acts as an electron carrier in the process, shuttling energy where it is needed.
But NAD+ does far more than power your mitochondria. It activates a group of enzymes called sirtuins. Sirtuins regulate inflammation, DNA repair, stress response, and even which genes get switched on or off. When NAD+ declines, sirtuin activity drops with it. The cellular maintenance programme that keeps you healthy starts to falter.
NAD+ also activates PARP enzymes, which are your cells' primary DNA repair machinery. Every day, your DNA sustains thousands of small errors and breaks. PARP enzymes find and fix them. Without adequate NAD+, that repair process becomes slower and less effective, and cumulative DNA damage is one of the established hallmarks of ageing.
In my cardiac nursing years, I watched how cellular energy failure shows up in the heart long before it shows up anywhere visible. Mitochondrial decline is not just a cosmetic concern. It is a systemic one. NMN works upstream of all of it. That is why I take it seriously as a longevity intervention rather than treating it as another wellness trend.
Why NAD+ declines with age
The decline happens through several converging mechanisms, which is part of why it is so pronounced by the time most patients notice its effects.
The first driver is an enzyme called CD38, which becomes increasingly active as we age. CD38 is an NAD+ consumer: it breaks the molecule down. The more of it is active, the faster NAD+ depletes.
Chronic inflammation compounds this significantly. Inflammation burns through NAD+ at a high rate. The kind of chronic, low-grade systemic inflammation I have written about in my inflammaging article, the kind driven by poor sleep, excess refined carbohydrates, unmanaged stress, and perimenopause, actively depletes NAD+ alongside its other destructive effects on tissue.
At the same time, your body's ability to synthesise NAD+ from dietary precursors slows down with age. The result is a convergence of problems: higher demand from inflammation and cellular stress, lower production capacity, and faster degradation through CD38 activity.
This is why NMN supplementation is compelling from a mechanistic standpoint. It bypasses the bottlenecks in the biosynthesis pathway and provides the direct precursor your cells need to make more NAD+.
What the research actually says
The evidence for NMN in humans is building steadily, and I want to present it honestly rather than selectively.
A 2022 clinical trial published in Nature Aging found that NMN supplementation significantly raised NAD+ levels in the bloodstream and muscle tissue of healthy older adults. Participants also showed improved muscle insulin sensitivity, which is directly relevant to metabolic ageing and the connection between blood sugar dysregulation, inflammatory burden, and the pace of biological decline.
A separate trial from Keio University School of Medicine demonstrated that 250mg of NMN daily was safe and well-tolerated over ten weeks, with measurable increases in NAD+ metabolites. Other studies have pointed to improvements in sleep quality, energy levels, and inflammatory markers.
David Sinclair's lab at Harvard has demonstrated in animal models that restoring NAD+ levels effectively reverses certain markers of vascular ageing. The blood vessel walls of older mice given NMN resembled those of younger animals. While human data on this specific point is still accumulating, the mechanistic case is compelling and completely aligned with the systems-level approach to ageing that informs everything at Juvenology.
I should also note what the research does not yet prove definitively. Human trials on NMN remain smaller and shorter than we would ideally want for a longevity intervention. The evidence is genuinely promising, and the mechanistic rationale is robust. But anyone presenting NMN as a proven treatment for ageing in the same way that a blood pressure medication treats hypertension would be overstating the current state of the literature. What we have is strong preclinical evidence, emerging human data, excellent safety data, and a compelling biological mechanism. That is a meaningful basis for a longevity protocol, approached with appropriate expectations.
Why bioavailability is the real issue
Here is the uncomfortable truth about most NMN supplements on the market: your digestive system is not kind to them.
Standard NMN capsules are exposed to stomach acid, degrading enzymes, and the first-pass effect in the liver before a fraction of the original dose reaches your bloodstream. You might take 500mg and absorb 50mg. The molecule is real. The research is real. But most of what you swallow never arrives where it needs to go.
This is specifically why we chose HINNAO NMN. HINNAO uses patented Smart Spheres Technology, a high-stability liposomal delivery system that encapsulates NMN in lipid-sized particles and delivers it via sublingual absorption. You hold the liquid under your tongue for 60 to 90 seconds. The highly vascularised mucous membrane absorbs the compound directly into the bloodstream, bypassing the digestive tract entirely.
In independent third-party laboratory testing, HINNAO achieved 83% absorption within 90 seconds. Compare that to the 10 to 30% absorption typical of standard oral capsules and the clinical significance becomes clear. You are not just taking a larger dose. You are actually getting the molecule where it needs to go.
This matters enormously in the context of longevity medicine. The difference between an intervention that works and one that does not is often not the compound itself but whether it reaches its target tissue at a meaningful concentration. Bioavailability is the variable that separates genuine clinical effect from expensive supplementation theatre.
NMN vs NAD+: understanding the difference
Patients often ask why we offer both HINNAO NMN and HINNAO NAD+ as separate products. The distinction matters clinically.
NAD+ itself is a large molecule that does not cross cell membranes easily. It cannot be directly absorbed intact from a standard oral supplement. NMN is its immediate precursor: smaller, more stable, and readily converted to NAD+ inside the cell once absorbed.
Some research suggests NMN converts to NAD+ particularly efficiently in muscle tissue, while direct NAD+ supplementation via sublingual delivery, which HINNAO achieves, may have advantages in other tissue types including the brain and liver. For a comprehensive longevity protocol, there is a compelling argument for both, used on different days or in rotation under clinical guidance.
This is exactly the kind of nuance that longevity medicine training allows us to bring to supplement decisions at Juvenology. These are not simply retail recommendations. They are evidence-informed choices based on understanding the biochemistry, the research, and the specific biological picture of the individual in front of us.
Who benefits most from NMN
NMN is relevant at any age, but its impact becomes most pronounced from the late 30s onward, which is when NAD+ decline starts to become clinically meaningful.
Those most likely to benefit include people experiencing persistent fatigue despite adequate sleep, which may reflect mitochondrial inefficiency rather than simply lifestyle factors. Patients with elevated inflammatory markers on a blood panel, where NAD+ depletion is both a consequence and an amplifier of the inflammatory burden. Perimenopausal and postmenopausal women, where menopause significantly accelerates NAD+ depletion as oestrogen decline compounds the existing age-related trajectory. And anyone pursuing a comprehensive longevity protocol, for whom NAD+ pathway support is one of the most evidence-based cellular interventions currently available.
If you are already using our Advanced Blood Panel, your results can help identify whether NAD+ pathway markers suggest supplementation is indicated and at what dose. This personalised, evidence-led approach is what distinguishes a longevity medicine consultation from simply reading a supplement label.
How to take HINNAO NMN
Take 1ml daily. Using the pipette, hold the liquid under your tongue for 60 to 90 seconds before swallowing. This allows the Smart Spheres to deliver the NMN directly through the mucous membrane into the bloodstream. Morning is the preferred time for best effect on energy levels and circadian rhythm alignment.
HINNAO NMN is pharmaceutical grade, vegan-friendly, and free from sugar, gluten, dairy, and GMOs. It is packaged in premium glass to prevent oxidation, which matters: NMN is sensitive to light and heat, and the packaging is part of the product's effectiveness.
A note on realistic expectations
I want to close with something I always say in clinic when patients ask about longevity supplements.
The goal of NMN supplementation is not to feel different tomorrow. It is to slow the biological processes that will make you feel significantly different in ten years if they are left unaddressed. NAD+ decline is gradual and largely silent until it is not. Supplementing to maintain NAD+ pathway function is a preventive intervention, not a treatment for an acute symptom.
That framing matters. Patients who approach NMN expecting an energy drink effect are likely to be disappointed. Patients who understand it as one component of a broader longevity strategy, alongside sleep, movement, stress management, adequate protein, and where appropriate, clinical treatments that support cellular regeneration, will use it correctly and benefit from it meaningfully.
NAD+ science is one of the most rapidly evolving areas in longevity medicine. The research is genuinely exciting, and the mechanistic case for NMN supplementation is robust. The key variable is ensuring what you take actually reaches your cells. On that front, HINNAO's delivery technology represents a meaningful step beyond the standard capsule market.
"In cardiac nursing I learned to think about cellular energy as a clinical variable, not a wellness concept. When mitochondria fail, everything downstream fails. NMN is one of the most evidence-informed ways we currently have to support that upstream function. That is why it has a place in a serious longevity protocol." — Nurse Marina, NMC Registered, BACN Member, JCCP Verified, Physician of Longevity, Juvenology Clinic
Explore our full Longevity Medicine approach at Juvenology.
About the author
Nurse Marina is the founder of Juvenology Clinic in Maidstone, Kent, and one of the UK's leading voices in longevity-focused aesthetic medicine.
Marina trained as a registered nurse and spent six years as a cardiac nurse at KIMS Hospital in Maidstone, developing a deep foundation in vascular anatomy, systemic physiology, and evidence-based clinical practice. She subsequently worked as an aesthetic nurse specialist at Spencer Private Hospitals before founding Juvenology, where she combines regenerative aesthetic treatments with longevity medicine to address both the visible and biological dimensions of ageing.
Marina holds an Executive Master of Science in Longevity from the Geneva College of Longevity Science, has completed the Healthy Longevity Clinician Programme through the National University of Singapore, and holds qualifications in hormonal health from the Marion Gluck Academy.
She is NMC Registered, BACN Member, JCCP Verified, ACE Group Registered, a Member of the Royal College of Nursing, ICO Registered, and recognised by the Professional Standards Authority.
Juvenology is based in Maidstone and serves patients across Kent, including Tunbridge Wells, Sevenoaks, Kings Hill, West Malling, and beyond.
Further reading and clinical references: